Related parties

The Company has a long-term pharmaceutical distribution agreement with AmerisourceBergen pursuant to which the Company sources branded and generic pharmaceutical products from AmerisourceBergen principally for its U.S. operations. Additionally, AmerisourceBergen receives sourcing services for generic pharmaceutical products.

Related party transactions with AmerisourceBergen (in millions):



	Three months ended November 30,
	2018		2017
Purchases, net	$	14,322	$	11,604



	November 30, 2018		August 31, 2018
Trade accounts payable, net	$	6,246	$	6,274